ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Squamous Cell Carcinoma of Head and Neck is on this study

  • ClinicalTrials.gov files the study under Squamous Cell Carcinoma of Head and Neck.
  • GPT-6 Astra (Medium) judged the term right: what the study is about. Oct 20 (day only)
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Squamous Cell Carcinoma of Head and Neck.
4 links0 made here, not in the record8 judgments3 judges (the rules as one: Rule based)0 record changes seen
GPT-6 Astra (Medium)Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04290546CIML NK Cell in Head & NeckCancerDana-Farber Cancer InstitutePhase 1 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSSquamous Cell Carcinoma of …The registry's MeSH filing›Oct 20 · GPT-6 Astra (Medium) · RightAs of now · Rule based · Main conditionMain conditionDRUGSNogapendekin alfa inbakiceptEntry “Interleukin-15 Superagonist (N…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundIpilimumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerCetuximabIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Oct 20Squamous Cell Carcinoma of Head and NeckGPT-6 Astra (Medium)RightCurrent
Nov 2Nogapendekin alfa inbakiceptClaude Opus 5.5BackgroundCurrent
Nov 2IpilimumabClaude Opus 5.5Background · partnerCurrent
Nov 2CetuximabClaude Opus 5.5BackgroundCurrent
Nov 18Nogapendekin alfa inbakiceptRule based · role ruleBackgroundAgrees
Nov 18IpilimumabRule based · role ruleBackgroundAgrees
Nov 18CetuximabRule based · role ruleBackgroundAgrees
As of nowSquamous Cell Carcinoma of Head and NeckRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.